Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: PENS vs TENS for Hand Function in Multiple Sclerosis [NA]
A completed clinical trial comparing percutaneous electrical nerve stimulation (PENS) versus transcutaneous electrical nerve stimulation (TE…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042 Cell Injection in the Treatment of Multiple Sclerosis (MS). [EARLY_Phase 1]
An open-label, single-arm early Phase 1 trial evaluating the safety and preliminary efficacy of a CD20 monoclonal antibody combined with NK0…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Conventional Multidisciplinary Gait Rehabilitation VR Robotic Self-balancing Based Gait Rehabilitation [NA]
A completed clinical trial evaluating conventional multidisciplinary gait rehabilitation using virtual reality and robotic self-balancing ga…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis [NA]
A clinical trial evaluating immersive virtual reality and exercise programs for people with multiple sclerosis has completed.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Palliative Care Model Impact on Knowledge and Attitudes [NA]
This entry reports a registered clinical trial evaluating a palliative care model and its impact on knowledge and attitudes in individuals w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: An Open-label Study of AZD0120 in Adults With Multiple Sclerosis [Phase 1]
This is an open-label Phase 1 clinical trial of AZD0120 in adults with Multiple Sclerosis. The trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality? [NA]
A multicenter prospective study protocol in multiple sclerosis evaluating the occurrence of relapses without radiological evidence to determ…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Fatigue and Mental Well-Being in MS Patients(Multiple Sclerosis) [NA]
A clinical trial sponsored by Artvin Coruh University is currently recruiting to assess fatigue and mental well-being in individuals with Mu…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis [Phase 1]
This clinical trial update outlines a Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and pharmacodynamics of P-CD19C…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Pathological Basis of MRI Signal Changes in Multiple Sclerosis
NINDS-sponsored clinical study investigating the pathological basis of MRI signal changes in multiple sclerosis; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis [Phase 3]
Sanofi is conducting a Phase 3 non-inferiority trial comparing subcutaneous Frexalimab to intravenous administration in adults with multiple…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases [Phase 1]
A Phase 1 trial evaluating the safety and preliminary efficacy of KITE-363 in relapsed/refractory autoimmune neurologic diseases is currentl…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Effects of Sleep Quality on Functional and Cognitive Outcomes in Multiple Sclerosi
A clinical trial update examines whether sleep quality influences functional and cognitive outcomes in people with multiple sclerosis. The s…
-
FDA approval · 2026-04-20FDA Approved: DALFAMPRIDINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for dalfampridine (generic). The approval enables the marketing of a generic …
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging [Phase 1]
Phase 1 clinical trial update evaluating ferumoxytol-enhanced 7 Tesla MRI to characterize inflammation in multiple sclerosis; the study stat…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Fatigue in MS: From Invisible to Measurable
This is a completed clinical trial update from University Medical Center Groningen addressing fatigue in multiple sclerosis and how the cond…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Remote Therapeutic Monitoring Exercise Tracking [NA]
This update notes a remote therapeutic monitoring and exercise-tracking clinical trial focused on Parkinson disease and multiple sclerosis. …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Nursing Students' Brain/MS Immersive Three-Dimensional Learning Activity [NA]
This entry reports an active but non-recruiting clinical trial from Hunter College investigating an immersive three-dimensional learning act…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
This clinical trial update announces an ongoing MRI-based study to evaluate activity in multiple sclerosis, sponsored by NINDS, currently re…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Effectiveness of Cryotherapy on the Fatigue of Patients With Multiple Sclerosis [NA]
A completed clinical trial evaluating the effectiveness of cryotherapy on fatigue in patients with multiple sclerosis. The study is listed o…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis [NA]
This clinical trial update reports on a study investigating autonomic nervous system involvement in multiple sclerosis. The trial is current…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Serum GFAP, NfL, VEGF and Clinical Progression in Progressive MS
This clinical trial update from Ondokuz Mayıs University investigates serum biomarkers GFAP, NfL, and VEGF and their relation to clinical pr…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Improving Cognitive Recovery in Multiple Sclerosis [NA]
King's College London is conducting a clinical trial to improve cognitive recovery in people with multiple sclerosis. The study is currently…
-
EMA approval · 2026-04-16EMA Authorised: Ocrevus (ocrelizumab) — Roche Registration GmbH
The European Medicines Agency authorised Ocrevus (ocrelizumab) for treating multiple sclerosis, with Roche Registration GmbH as the marketin…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis [Phase 4]
This clinical trial update concerns ocrelizumab discontinuation in relapsing multiple sclerosis, with a Phase 4 study currently recruiting.